Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of$ 1.66 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.01%. A quarter ago, it was expected that this specialty pharmaceutical company would post earnings of$ 1.56 per share when it actually produced earnings of $1.62, delivering a surprise of 3.85%.Over the ...